Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Current Leases (2019 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Current Leases over the past 7 years, most recently at $4.0 million for Q1 2025.

  • Quarterly results put Current Leases at $4.0 million for Q1 2025, down 4.64% from a year ago — trailing twelve months through Feb 2025 was $4.0 million (down 4.64% YoY), and the annual figure for FY2024 was $4.0 million, up 212.05%.
  • Current Leases for Q1 2025 was $4.0 million at Lifecore Biomedical, Inc. \De\, down from $4.1 million in the prior quarter.
  • Over the last five years, Current Leases for LFCR hit a ceiling of $4.4 million in Q1 2022 and a floor of $977000.0 in Q2 2021.
  • Median Current Leases over the past 5 years was $4.0 million (2024), compared with a mean of $2.8 million.
  • Peak annual rise in Current Leases hit 704.0% in 2021, while the deepest fall reached 77.91% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Current Leases stood at $1.2 million in 2021, then skyrocketed by 255.83% to $4.3 million in 2022, then plummeted by 72.47% to $1.2 million in 2023, then surged by 245.01% to $4.1 million in 2024, then dropped by 3.64% to $4.0 million in 2025.
  • The last three reported values for Current Leases were $4.0 million (Q1 2025), $4.1 million (Q4 2024), and $4.1 million (Q3 2024) per Business Quant data.